000205506 001__ 205506
000205506 005__ 20180913063004.0
000205506 0247_ $$2doi$$a10.4414/smw.2014.14044
000205506 022__ $$a1424-7860
000205506 02470 $$2ISI$$a000346064000003
000205506 037__ $$aARTICLE
000205506 245__ $$aNanotechnology in medicine: European research and its implications
000205506 260__ $$bE M H Swiss Medical Publishers Ltd$$c2014$$aMuttenz
000205506 269__ $$a2014
000205506 300__ $$a7
000205506 336__ $$aReviews
000205506 520__ $$aIn this study, we explore and discuss nanoparticles and nanoscale materials and their use in medicine (nanomedicine) and pharmaceutics (nanopharmaceutics). The study is aimed at shedding light on this highly multidisciplinary research field and at examining the influence of research funding, industrial applications, and legal and regulatory frameworks on the research in this field, a clear understanding of which is essential to efficiently support the translation of research findings into industrial and clinical applications and to enable access to a larger society.
000205506 6531_ $$ananotechnology
000205506 6531_ $$ananomedicine
000205506 6531_ $$ananoparticle
000205506 6531_ $$atranslational research
000205506 700__ $$0240861$$g113472$$uMatSearch Consulting, CH-1009 Pully, Switzerland$$aHofmann-Amtenbrink, Margarethe
000205506 700__ $$0240408$$g105410$$uEcole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland$$aHofmann, Heinrich
000205506 700__ $$aHool, Alessandra$$uMatSearch Consulting, CH-1009 Pully, Switzerland
000205506 700__ $$aRoubert, Francois
000205506 773__ $$j144$$tSwiss Medical Weekly
000205506 909C0 $$xU10340$$0252068$$pLTP
000205506 909CO $$pSTI$$preview$$ooai:infoscience.tind.io:205506
000205506 917Z8 $$x105410
000205506 937__ $$aEPFL-REVIEW-205506
000205506 973__ $$rREVIEWED$$sPUBLISHED$$aEPFL
000205506 980__ $$aREVIEW